Home > FDA Public Workshop on External Defibrillators, December 15-16, 2010(2)

FDA Public Workshop on External Defibrillators, December 15-16, 2010(2)

The Food and Drug Administration (FDA) is holding a public
workshop to share FDA’s understanding of the risks and
benefits of external defibrillators, to clarify FDA’s current
expectations for how industry should identify, report, and take
action on problems observed with these devices, and to promote
innovation for next-generation devices that will bring safer, more
effective external defibrillators to market.

If you wish to attend this workshop, you must register
by close of business on November 29, 2010.

There is no fee to register for the Workshop and registration
will be on a first-come, first-served basis. Early registration is
recommended because seating is limited.

If you wish to make an oral presentation during any of the open
comment sessions at the meeting, you must indicate this at the time
of registration. FDA requests that presentations focus on the areas
defined in the agenda from this meeting. You should also identify
which discussion topic you wish to address in your presentation and
you must submit a brief statement that describes your experience
and/or expertise relevant to your proposed presentation to
megan.moynahan@fda.hhs.gov[5]. In order to keep each open session
focused on the discussion topic at hand, each oral presentation
should address only one discussion topic. FDA will do its best to
accommodate requests to speak.

If you need special accommodations due to a disability, please
contact Susan Monahan at 301-796-5661, at
susan.monahan@fda.hhs.gov[6] at least 7 days in advance of the
meeting.

The FDA is holding a public workshop to share FDA?s understanding of the risks and benefits of external defibrillators, to clarify FDA?s current expectations for how industry should identify, report, and take action on problems observed with these devices